LOX and neoplasm: Of note, 12/15-LOX-derived oxylipins were detected to be at a much lower level than the tumor control group, Lipo-DOX–2 group (30.2%), Lipo-DOX–2 + Avastin–5 (21%), and dLGG–10 + Lipo-DOX–2 group (52.4%).